Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs in serious ocular and rare diseases. Adverum is advancing the clinical development of its novel gene therapy candidate, ADVM-022, as a on...
Adverum Biotechnologies (an Eli Lilly subsidiary) seeks a Process Development Scientist (12-month contract) to advance AAV upstream processes, analytical characterization, and tech transfer in a cGMP environment.